Search clinical trials for: TKI intolerance

Total 2001 results

Sung Yong Lee
Yuhan Corporation

Recruiting

A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy (PLATINUM)

Non-small Cell Lung Cancer Stage III | Non-squamous Non-small-cell Lung Cancer | EGFR Positive Non-small Cell Lung Cancer

Korea, Republic of
Zhongda Hospital

Recruiting

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC (CHANCE2202)

Hepatocellular Carcinoma

China
Zhongda Hospital

Recruiting

TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC (CHANCE2201)

Hepatocellular Carcinoma

China
Vertex Pharmaceuticals Incorporated
CRISPR Therapeutics

Recruiting

Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)

Sickle Cell Disease | Hemoglobinopathies | Hematological Diseases | Hydroxyurea Failure | Hydroxyurea Intolerance

United States, Italy, United Kingdom, Germany
Jin Hyoung Kang

Recruiting

Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.

Lung Neoplasms

Korea, Republic of
Huazhong University of Science and Technology

Not yet recruiting

Effect of Selenium Supplementation on Glycemic Control in Patients With Type 2 Diabetes or Prediabetes

PreDiabetes | Type 2 Diabetes
Diabetes Foundation, India
Almond Board of California; National Diabetes Obesity and Cholesterol Foundation

Recruiting

Almonds and Cognitive Functions

PreDiabetes

India
N.N. Blokhin National Medical Research Center of...

Recruiting

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy (TRUST)

Non Small Cell Lung Cancer | EGFR Gene Mutation | T790M

Russian Federation
Shenzhen Second People's Hospital

Recruiting

Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.

Chronic Myeloid Leukemia, Chronic Phase | Olverembatinib | Tyrosine Kinase Inhibitors

China
University of Missouri, Kansas City
Children's Mercy Hospital Kansas City; University of Massachusetts, Amherst; University... and other collaborators

Recruiting

Social Determinants and a Diabetes Prevention Program Tailored for African Americans (FIT4ALL)

PreDiabetes | Overweight and Obesity

United States
University of Calgary

Recruiting

Hypercapnia in Orthostatic Hypotension

Orthostatic Hypotension | Neurogenic Orthostatic Hypotension

Canada
Cancer Institute and Hospital, Chinese Academy...

Recruiting

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Colorectal Neoplasms Malignant

China
Tata Memorial Hospital

Recruiting

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC (TARGET-01)

Non-small Cell Lung Cancer | Oligometastatic Disease | Driver Mutation

India
Ningbo No. 1 Hospital

Recruiting

Effect of Nutritional Supplements on Clinical Outcomes in Patients With Prediabetes and Obesity

Obesity | PreDiabetes

China
Brno University Hospital
Masaryk University

Recruiting

The Influence of Polymeric Versus Oligomeric Enteral Feeding on Tolerance and Nutritional Status in Paediatric Intensive Care Pilot (Polygomerpilot)

Enteral Feeding Intolerance

Czechia
TILT Biotherapeutics Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA)

Platinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditions

United States, Finland
Fudan University

Recruiting

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Carcinosarcoma | Sarcomatoid Carcinoma | PD-1 Immunotherapy | VEGFR-TKI

China
Zekai Tahir Burak Women's Health Research and Education...

Recruiting

Comparision of Two Different Feeding Method in Preterms

Enteral Feeding Intolerance

Turkey
Black Diamond Therapeutics, Inc.

Recruiting

Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Non-Small Cell Lung Cancer | NSCLC | Metastatic Lung Cancer | Metastatic Lung Non-Small Cell Carcinoma | EGF-R Positive Non-Small Cell Lung Cancer | Advanced Lung Carcinoma | EGFR-TKI Resistant Mutation | Advanced Non-Small Cell Squamous Lung Cancer | Epidermal Growth Factor Receptor C797S | Epidermal...

United States
Fondazione Italiana Linfomi - ETS

Recruiting

Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. (FIL_COLUMN)

Refractory Mantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma

Italy
The University of Hong Kong

Not yet recruiting

Digital Lifestyle Intervention For Diabetes/Pre-Diabetes

Obesity | PreDiabetes | Type 2 Diabetes

Hong Kong
University of Michigan
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

The Lifestyle Education About Prediabetes (Leap) Study (LEAP)

PreDiabetes

United States
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study

Breast Cancer

China
Centre of Postgraduate Medical Education

Recruiting

Cardioneuroablation: Comparison of Right Versus Left Atrial Approach in Patients With Reflex Syncope (ROMAN2)

Reflex Syncope

Poland
Erasmus Medical Center

Recruiting

ProSpecTive sAmpling in dRiver muTation Pulmonary Oncology Patients on Tyrosine Kinase Inhibitors (START-TKI) (START-TKI)

Non Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase Inhibitor

Netherlands
University Hospital, Bordeaux

Recruiting

Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors (SPICI)

Metastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score

France
Hasan Kalyoncu University

Not yet recruiting

The Effect of Health Education Given to Prediabetes Patients by Videoconferencing on Self-management and Exercise

PreDiabetes
National Taiwan University Hospital

Recruiting

Primary Tumor Resection With EGFR TKI for Stage IV NSCLC

NSCLC Stage IV

Taiwan
Medical College of Wisconsin
University College, London; Indiana University

Recruiting

Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome

Functional Gastrointestinal Disorders | Postural Orthostatic Tachycardia Syndrome | Hypermobile Ehlers-Danlos Syndrome | Autonomic Nervous System Disease | Autonomic Nervous System Imbalance

United States
University of Oregon

Recruiting

Histamine as a Molecular Transducer of Adaptation to Exercise

Postexercise Hypotension

United States
Bartın Unıversity

Not yet recruiting

Comparison of Cognitive and Motor Dual Task Performance in Individuals With Prediabetes and Diabetes

Diabetes Mellitus
Carmel Medical Center

Recruiting

Decrease Type II Diabetes in Gestational Diabetes Population

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Impaired Glucose Tolerance | Gestational Diabetes | Breastfeeding

Israel
R-Pharm International, LLC
Atlant Clinical LLC; Center for Pharmaceutical Analytics LLC; Unimed Laboratories... and other collaborators

Recruiting

Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever

Familial Mediterranean Fever | FMF

Armenia, Georgia, Russian Federation
Karolinska Institutet
Uppsala University; The Swedish Research Council; Capio Sankt Görans Hospital

Recruiting

Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) (MIMET)

ST Elevation Myocardial Infarction | PreDiabetes | Acute Myocardial Infarction | Non ST Elevation Myocardial Infarction

Sweden
Olivia Newton-John Cancer Research Institute
The Alfred; Austin Health; Peter MacCallum Cancer Centre, Australia; Royal Brisbane... and other collaborators

Recruiting

A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study) (I-FIRST)

Thyroid Cancer

Australia
Milton S. Hershey Medical Center

Not yet recruiting

The HEALiX: Comparing the Efficacy of the HEALiX Device With Wrist Restraints in a Critical Care Setting

Safety Issues | Device Dislodgement | Device Intolerance | Device Ineffective
Li Zhang, MD

Recruiting

Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance (ERSGATR)

The Diagnosis Was ALK Positive NSCLC | Second Generation ALK-TKI is Resistant | Efficacy of Ensatinib in This Subset of Patients

China
Shanghai EpimAb Biotherapeutics Co., Ltd.
Labcorp Corporation of America Holdings, Inc

Recruiting

EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

Neoplasms | Neoplasm Metastasis | Metastatic Gastrointestinal Carcinoid Tumor

United States, China
Fudan University

Recruiting

The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients

Pancreatic Cancer

China
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Donafenib Plus Sintilimab for Advanced HCC

Hepatocellular Carcinoma

China
University of Calgary

Recruiting

Study of Atomoxetine in the Prevention of Vasovagal Syncope (POST7)

Vasovagal Syncope

Canada
Lovisenberg Diakonale Hospital
University of Bergen

Not yet recruiting

Sucrase-isomaltase Deficiency as a Cause of Irritable Bowel Syndrome

Irritable Bowel Syndrome | Functional Gastrointestinal Disorders | Sucrase Isomaltase Deficiency | Sucrose Intolerance Due to Sucrase-Isomaltase Deficiency | Carbohydrate; Malabsorption
Affiliated Hospital of Nantong University

Recruiting

FLOR3 Gene Polymorphism in Predicting Outcomes of Tyrosine Kinase Inhibitor（TKI）Stopping in Chronic Myeloid Leukemia (NTU-CML-001)

CML | Treatment-free Remission | Folate

China
Sultan Abdulhamid Han Training and Research Hospital...

Recruiting

The Effect of Exercise on Quality of Life, Sleep Quality and Anxiety in Patients With Prediabetes (EFEXQULS) (EFEXQULS)

Depression | Quality of Life | Sleep | PreDiabetes | Anxiety | Physical Inactivity

Turkey
University of Pisa
Azienda Ospedaliero, Universitaria Pisana; University of Florence

Recruiting

Precision Medicine for Preventing Type 2 Diabetes: a Step Forward (PRE-MED2)

PreDiabetes

Italy
xiaolong zhao

Recruiting

Intervention Effect of Canagliflozin on Prediabetes in Patients With HIV.

PreDiabetes | Hiv

China
Yue Han
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure

Unresectable Hepatocellular Carcinoma

China
Beijing University of Chinese Medicine

Recruiting

Tangningtongluo Tablet for People With Prediabetes

Prediabetes

China
Signos Inc

Recruiting

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

Metabolic Syndrome | Weight Loss | Glucose Intolerance | Pre-diabetes | Central Obesity | Metabolic Glucose Disorders

United States
University of Virginia
Haydom Lutheran Hospital

Not yet recruiting

MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty

Metabolic Syndrome | Glucose Intolerance | Growth Failure | Intestinal Infection

Search clinical trials for: TKI intolerance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations